Icosagen is a leading biopharmaceutical company that provides cutting-edge solutions in protein production, therapeutic development, and diagnostics. They focus on custom services for antibody discovery, development, and manufacturing, offering expertise in a wide range of applications across healthcare and research sectors.

Icosagen specialises in CRDMO services, particularly in protein production, antibody engineering, and protein analytics. Their technologies, including HybriFree™ and IcoCell® platforms, support the efficient production of complex proteins and antibodies. Icosagen's services are designed for clients in the biotech and pharmaceutical industries.

Key Products and Services

• Antibody discovery (phage display, hybridoma sequencing)
• Antibody development (bispecific antibody engineering, affinity maturation)
• Protein production (GMP manufacturing, transient production)
• Protein purification and analytics
• Cell line development and protein expression
• Therapeutic protein production (oncology, immuno-oncology)

Icosagen's commitment to high-quality, reliable services has made them a trusted partner for biopharma clients, helping to bring novel therapeutics from discovery to development.